Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,178 recruiting studies in this area right now.
By phase
- Not applicable2,713
- Phase 2361
- Phase 4321
- Phase 1290
- Phase 3288
- Phase 1/Phase 2141
- Phase 2/Phase 364
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University31
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California235
- Maryland146
- Alabama89
- New York76
- Florida74
- Texas61
- Massachusetts56
- Arizona47
- Pennsylvania45
- Illinois42
Recruiting studies4,178 total
- NCT07297966RecruitingPhase 2
Probiotics for recurrent respiratory infections in children
This trial tests if a daily probiotic can help young children who get frequent respiratory infections like colds and coughs. It aims to see if the probiotic reduces how often infections happen.
Xingyi, GuangdongAges 1 day–6 years - NCT07298785Recruiting
HIV prevention study led by peers for women
This study tests a peer-led approach to HIV prevention for women. It looks at whether having a peer (someone like you) help choose and use prevention tools can work better than standard care.
KampalaAges 15 years+ - NCT07298889Recruiting
Higher pressure support for pneumonia or ARDS patients
This trial tests whether using a higher level of pressure support (called PEEP) during noninvasive mask breathing can help people with pneumonia or ARDS (a serious lung condition) recover. It might be a good option if you need help breathing with a mask and meet the oxygen level requirements.
ChongqingAges 18 years+ - NCT07299500Recruiting
Toxoplasmosis study in non-HIV immune compromised patients
This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.
StrasbourgAges 18 years+ - NCT07299565Recruiting
Knee infection trial: drug levels after spacer surgery
This trial studies how antibiotics reach the knee joint after a temporary antibiotic spacer is placed. It may help improve treatment for people having two-stage surgery for a knee prosthesis infection.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07299591Recruiting
Antibiotic levels in hip infection spacer study
This study is testing a new way to measure how well antibiotics reach the infected area around a hip implant during a two-stage replacement surgery. If you are already planning this surgery, researchers want to see if the levels of antibiotics in the spacer are high enough to fight the infection.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07300254Recruiting
Syphilis shedding study in women and men who have sex with women only
This study looks at how syphilis bacteria are shed from the body in people with early syphilis. It aims to understand how the infection might spread, especially among women and men who have sex only with women.
Melbourne, VictoriaAges 18 years+ - NCT07300267RecruitingPhase 1
Study of a new pneumococcal vaccine for infants and toddlers
This trial tests a new vaccine called V118C to protect children against pneumococcal disease. It is for two age groups: toddlers aged 12-15 months who already had 3 doses of a standard pneumococcal vaccine, and babies about 2 months old who have not had any pneumococcal vaccine yet.
Madera, CaliforniaAges 2 months–1.3 years - NCT07300644RecruitingPhase 2
Pneumococcal vaccine trial for infants and children up to 5 years
This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.
Huanggang, HubeiAges 1 month–5 years - NCT07301320RecruitingPhase 2
Epetraborole for Mycobacterium abscessus lung infection
This study tests an investigational medication called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus bacteria. You may be able to join if your infection is stable enough to delay standard treatment and you have symptoms like cough, fatigue, or weight loss.
Portland, OregonAges 18 years+ - NCT07302256RecruitingPhase 1
Flu vaccine trial for adults 60 and older
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
Wuhan, HubeiAges 60 years+ - NCT07302295Recruiting
How COVID-19 affected suicidal behavior in kids
This study looks at how the COVID-19 pandemic affected suicidal behavior in children and teens. Researchers want to compare episodes that happened during the pandemic (2020-2022) with those just before (2018-2019) to understand if there was a change.
BronAges 8–18 - NCT07303101Recruiting
One-stage replacement for candida joint infections
This study looks at whether a single surgery to replace a hip or knee joint is effective for infections caused by Candida fungus. It may help people who need a joint replacement due to this type of infection.
StrasbourgAges 18 years+ - NCT07303114Recruiting
HIV screening missed in general practice study
This study looks at missed chances for HIV testing in general doctor offices. It focuses on people who were diagnosed with HIV between 2021 and 2024.
StrasbourgAges 18 years+ - NCT07303699RecruitingPhase 2
Atorvastatin with TB meds: a drug study for TB patients
This study tests if adding the cholesterol drug atorvastatin to standard TB treatment can help clear the infection faster. It looks at how the body processes the drugs and how well they work together.
Zaria, Kaduna StateAges 12 years+ - NCT07307170Recruiting
Mirogabalin for shingles pain study
This trial tests a new pain medicine called mirogabalin for people with shingles pain that started within the last 30 days. It aims to see if the drug can safely reduce moderate to severe pain.
BeijingAges 18 years+ - NCT07307586RecruitingPhase 3
Azvudine for new hepatitis B patients
This study tests a new pill (azvudine) to see if it can cure chronic hepatitis B in people who have never been treated before. It is for those with active infection and elevated liver enzymes.
Zhengzhou, HenanAges 18–65 - NCT07307976Recruiting
Testing a new pain drug for shingles pain
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
BeijingAges 18 years+ - NCT07308457Recruiting
Comparing infection monitoring vs. antibiotic prevention in stem cell transplant
This trial compares two ways to prevent infections after a stem cell transplant: using a standard antibiotic (ceftriaxone) or closely watching for germs in the blood and treating only if needed. It aims to find which method is safer and more effective for people receiving a stem cell transplant.
Szczecin, West Pomeranian VoivodeshipAges 18 years+ - NCT07308808RecruitingEarly Phase 1
Safety of a live bacteria solution for bladder infections
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07308886RecruitingPhase 2
CYT107 for Kaposi sarcoma in HIV patients with low CD4
This trial tests an experimental drug (CYT107) that boosts the immune system to help fight Kaposi sarcoma in people with HIV who have a low CD4 count despite good HIV treatment. It aims to see if the drug can improve KS tumors and quality of life.
Bethesda, MarylandAges 18–120 - NCT07310472Recruiting
Nasal flu vaccine for children in daycare
This trial is testing a nasal spray flu vaccine given to children at their daycare or a healthcare facility. It aims to make getting the vaccine easier and more convenient for families.
TurkuAges 2–6 - NCT07311343RecruitingPhase 4
Mouth care and antibiotics to prevent pneumonia after brain bleed
This trial tests whether a special mouth rinse and preventive antibiotics can lower the risk of pneumonia after a brain bleed (intracerebral hemorrhage). If you've had a small bleed in the upper part of the brain and are at risk for pneumonia, this study may help.
Beijing, Beijing MunicipalityAges 18–80 - NCT07311395Recruiting
Gentamicin injection to prevent infection after planned C-section
This study tests whether a local injection of gentamicin, an antibiotic, into the incision area can help prevent infections after a planned C-section. It may offer extra protection beyond standard antibiotics.
NahariyaAges 18 years+
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,178 recruiting infectious disease studies from the U.S. registry right now, out of 7,113 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.